Zobrazeno 1 - 10
of 678
pro vyhledávání: '"A. Westgeest"'
Autor:
J. C. Janssen, B. van Dijk, K. de Joode, M. J. B. Aarts, F. W. P. J. van den Berkmortel, C. U. Blank, M. J. Boers-Sonderen, A. J. M. van den Eertwegh, J. W. B. de Groot, M. Jalving, M. J. A. de Jonge, A. Joosse, E. Kapiteijn, A. M. Kamphuis-Huismans, K. A. T. Naipal, D. Piersma, B. Rikhof, H. M. Westgeest, G. Vreugdenhil, E. Oomen-de Hoop, E. E. A. P. Mulder, Astrid A. M. van der Veldt
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Patients with irresectable stage III or metastatic melanoma presenting with poor prognostic factors are usually treated with a combination of immune checkpoint inhibitors (ICIs), consisting of ipilimumab and nivolumab. This combin
Externí odkaz:
https://doaj.org/article/ca4c9e5c51fc40759d196932967e286e
Autor:
Lindsay V. M. Leek, Jessica C. L. Notohardjo, Karlijn de Joode, Eline L. Velker, John B. A. G. Haanen, Karijn P. M. Suijkerbuijk, Maureen J. B. Aarts, Jan Willem B. de Groot, Ellen Kapiteijn, Franchette W. P. J. van den Berkmortel, Hans M. Westgeest, Tanja D. de Gruijl, Valesca P. Retel, Edwin Cuppen, Astrid A. M. van der Veldt, Mariette Labots, Emile E. Voest, Joris van de Haar, Alfons J. M. van den Eertwegh
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract We evaluated the prognostic value of hypoalbuminemia in context of various biomarkers at baseline, including clinical, genomic, transcriptomic, and blood-based markers, in patients with metastatic melanoma treated with anti-PD-1 monotherapy
Externí odkaz:
https://doaj.org/article/0b86698c5e3b43c28f9ef4dd875f5025
Autor:
Maud Rijnders, J. Alberto Nakauma-González, Debbie G. J. Robbrecht, Alberto Gil-Jimenez, Hayri E. Balcioglu, Astrid A. M. Oostvogels, Maureen J. B. Aarts, Joost L. Boormans, Paul Hamberg, Michiel S. van der Heijden, Bernadett E. Szabados, Geert J. L. H. van Leenders, Niven Mehra, Jens Voortman, Hans M. Westgeest, Ronald de Wit, Astrid A. M. van der Veldt, Reno Debets, Martijn P. Lolkema
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Immune checkpoint inhibitors (ICI) improve overall survival in patients with metastatic urothelial cancer (mUC), but therapeutic success at the individual patient level varies significantly. Here we identify predictive markers of response, b
Externí odkaz:
https://doaj.org/article/5c826962a5fb45ffbb47fc08f0218098
Autor:
van Duin, Isabella A.J., Schuiveling, Mark, ter Maat, Laurens S., van Amsterdam, Wouter A.C., van den Berkmortel, Franchette, Boers-Sonderen, Marye, de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Labots, Mariette, Piersma, Djura, Schrader, Anne M.R., Vreugdenhil, Gerard, Westgeest, Hans, Veta, Mitko, Blokx, Willeke A.M., van Diest, Paul J., Suijkerbuijk, Karijn P.M.
Publikováno v:
In European Journal of Cancer September 2024 208
Autor:
van Duin, I.A.J., Schuiveling, M., ter Maat, L.S., Veta, M., van Eijs, M.J.M., Verheijden, R.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., Hospers, G.A.P., Labots, M., de Groot, J.W.B., Kapiteijn, E., Piersma, D., Vreugdenhil, G., Westgeest, H., Schrader, A.M.R., van Diest, P.J., Blokx, W.A.M., Suijkerbuijk, K.P.M.
Publikováno v:
In Immuno-Oncology and Technology December 2024 24
Autor:
Phyllis van der Ploeg, Cynthia SE. Hendrikse, Anna MJ. Thijs, Hans M. Westgeest, Huberdina PM. Smedts, M Caroline Vos, Mathilde Jalving, Christianne AR. Lok, Ingrid A. Boere, Maaike APC. van Ham, Petronella B. Ottevanger, Anneke M. Westermann, Constantijne H. Mom, Roy I. Lalisang, Sandrina Lambrechts, Ruud LM. Bekkers, Jurgen MJ. Piek
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23170- (2024)
Objective: Ovarian cancer is the fifth cause of cancer-related death among women. The benefit of targeted therapy for ovarian cancer patients is limited even if treatment is stratified by molecular signature. There remains a high unmet need for alter
Externí odkaz:
https://doaj.org/article/ec80d08ac0c84967956ced20e2dd05ff
Autor:
Hilin Yildirim, Christiaan V Widdershoven, Maureen JB Aarts, Axel Bex, Haiko J Bloemendal, Deirdre M Bochove-Overgaauw, Paul Hamberg, Karin H Herbschleb, Tom van der Hulle, Brunolf W Lagerveld, Martijn GH van Oijen, Sjoukje F Oosting, Johannes V van Thienen, Astrid AM van der Veldt, Hans M Westgeest, Evelijn E Zeijdner, Katja KH Aben, Corina van den Hurk, Patricia J Zondervan, Adriaan D Bins
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Ongoing research in the field of both localized, locally advanced and metastatic renal cell carcinoma has resulted in the availability of multiple treatment options. Hence, many questions are still unanswered and await further res
Externí odkaz:
https://doaj.org/article/7899867013894664a81995245ef9db90
Autor:
K. de Joode, W. S. van de Geer, G. J. L. H. van Leenders, P. Hamberg, H. M. Westgeest, A. Beeker, S. F. Oosting, J. M. van Rooijen, L. V. Beerepoot, M. Labots, R. H. J. Mathijssen, M. P. Lolkema, E. Cuppen, S. Sleijfer, H. J. G. van de Werken, A. A. M. van der Veldt
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Differences in the clinical course and treatment responses in individual patients with advanced renal cell carcinoma (RCC) can largely be explained by the different genomics of this disease. To improve the personalized treatment strategy and
Externí odkaz:
https://doaj.org/article/0bbbda1544a74e2ab59f748e487111a1
Autor:
Koole, Simone N *, Huisman, Atse H, Timmers, Lonneke, Westgeest, Hans M, van Breugel, Edwin, Sonke, Gabe S, van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh
Publikováno v:
In The Lancet Oncology March 2024 25(3):e126-e135
Autor:
van der Ploeg, Phyllis, Hendrikse, Cynthia SE., Thijs, Anna MJ., Westgeest, Hans M., Smedts, Huberdina PM., Vos, M Caroline, Jalving, Mathilde, Lok, Christianne AR., Boere, Ingrid A., van Ham, Maaike APC., Ottevanger, Petronella B., Westermann, Anneke M., Mom, Constantijne H., Lalisang, Roy I., Lambrechts, Sandrina, Bekkers, Ruud LM., Piek, Jurgen MJ.
Publikováno v:
In Heliyon 15 January 2024 10(1)